Fangzhou Jiao

1.5k total citations · 1 hit paper
39 papers, 1.2k citations indexed

About

Fangzhou Jiao is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Fangzhou Jiao has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Fangzhou Jiao's work include Liver Disease Diagnosis and Treatment (9 papers), Histone Deacetylase Inhibitors Research (8 papers) and Inflammasome and immune disorders (6 papers). Fangzhou Jiao is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Histone Deacetylase Inhibitors Research (8 papers) and Inflammasome and immune disorders (6 papers). Fangzhou Jiao collaborates with scholars based in China and United States. Fangzhou Jiao's co-authors include Zuojiong Gong, Yao Wang, Qian Chen, Chunxia Shi, Haiyue Zhang, Luwen Wang, Wenbin Zhang, Maohua Pei, Lu-Wen Wang and Hong Zhang and has published in prestigious journals such as Scientific Reports, Brain Research and Life Sciences.

In The Last Decade

Fangzhou Jiao

37 papers receiving 1.2k citations

Hit Papers

The Beneficial Roles of S... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangzhou Jiao China 19 591 261 197 149 130 39 1.2k
Xiaoyu Chen China 19 530 0.9× 152 0.6× 183 0.9× 99 0.7× 150 1.2× 62 1.1k
Chunxia Shi China 16 466 0.8× 211 0.8× 161 0.8× 42 0.3× 108 0.8× 39 865
Virginia Pardo Spain 15 499 0.8× 630 2.4× 119 0.6× 84 0.6× 147 1.1× 28 1.3k
Sun‐O Ka South Korea 18 498 0.8× 244 0.9× 144 0.7× 240 1.6× 91 0.7× 22 1.0k
Gi Ryang Kweon South Korea 24 885 1.5× 270 1.0× 178 0.9× 112 0.8× 285 2.2× 51 1.9k
Yingqing Chen China 20 540 0.9× 201 0.8× 98 0.5× 37 0.2× 69 0.5× 37 857
Eun Sil Kang South Korea 23 550 0.9× 137 0.5× 100 0.5× 54 0.4× 127 1.0× 45 1.0k
Yuan Yuan China 27 853 1.4× 541 2.1× 230 1.2× 61 0.4× 201 1.5× 81 2.0k
Deqiang Huang China 16 722 1.2× 160 0.6× 106 0.5× 32 0.2× 248 1.9× 37 1.3k
Xiaolei Wang China 18 525 0.9× 234 0.9× 48 0.2× 62 0.4× 85 0.7× 44 1.2k

Countries citing papers authored by Fangzhou Jiao

Since Specialization
Citations

This map shows the geographic impact of Fangzhou Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangzhou Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangzhou Jiao more than expected).

Fields of papers citing papers by Fangzhou Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangzhou Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangzhou Jiao. The network helps show where Fangzhou Jiao may publish in the future.

Co-authorship network of co-authors of Fangzhou Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangzhou Jiao. A scholar is included among the top collaborators of Fangzhou Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangzhou Jiao. Fangzhou Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Rongrong, et al.. (2025). The sex differences in diseases progression and prognosis among persons with HIV and HBV coinfection. Scientific Reports. 15(1). 4018–4018. 1 indexed citations
2.
Wei, Jing, Yuan Li, Fangzhou Jiao, et al.. (2024). DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling. Brain Research. 1848. 149334–149334.
3.
Jiao, Fangzhou, et al.. (2022). SIRT6 Activator UBCS039 Inhibits Thioacetamide-Induced Hepatic Injury In Vitro and In Vivo. Frontiers in Pharmacology. 13. 837544–837544. 18 indexed citations
4.
Shi, Chunxia, Fangzhou Jiao, Yao Wang, et al.. (2022). SIRT3 inhibitor 3-TYP exacerbates thioacetamide-induced hepatic injury in mice. Frontiers in Physiology. 13. 915193–915193. 10 indexed citations
5.
Jiao, Fangzhou, Yao Wang, Qian Chen, et al.. (2021). Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome. Oxidative Medicine and Cellular Longevity. 2021(1). 5522708–5522708. 13 indexed citations
6.
Wang, Yao, Qian Chen, Fangzhou Jiao, et al.. (2021). Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site. Cell Death and Disease. 12(1). 41 indexed citations
7.
Shi, Chunxia, Yao Wang, Fangzhou Jiao, et al.. (2021). Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation. Frontiers in Physiology. 12. 683526–683526. 8 indexed citations
8.
Jiao, Fangzhou, et al.. (2020). SENP7 knockdown inhibited pyroptosis and NF-κB/NLRP3 inflammasome pathway activation in Raw 264.7 cells. Scientific Reports. 10(1). 16265–16265. 14 indexed citations
9.
Wang, Yao, Haiyue Zhang, Qian Chen, et al.. (2020). TNF‐α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Proliferation. 53(6). e12829–e12829. 157 indexed citations
10.
Chen, Qian, Yao Wang, Fangzhou Jiao, et al.. (2020). Betaine inhibits Toll-like receptor 4 responses and restores intestinal microbiota in acute liver failure mice. Scientific Reports. 10(1). 21850–21850. 29 indexed citations
11.
Chen, Hui, Yao Wang, Fangzhou Jiao, et al.. (2020). <p>Sinomenine Attenuates Acetaminophen-Induced Acute Liver Injury by Decreasing Oxidative Stress and Inflammatory Response via Regulating TGF-β/Smad Pathway in vitro and in vivo</p>. Drug Design Development and Therapy. Volume 14. 2393–2403. 37 indexed citations
13.
Zhang, Di, Yao Wang, Haiyue Zhang, et al.. (2019). Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication. Life Sciences. 223. 1–8. 14 indexed citations
14.
Chen, Qian, et al.. (2019). Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure. Life Sciences. 238. 116976–116976. 12 indexed citations
15.
Jiao, Fangzhou, Yao Wang, Wenbin Zhang, et al.. (2019). AGK2 Alleviates Lipopolysaccharide Induced Neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1. Journal of Neuroimmune Pharmacology. 15(2). 196–208. 25 indexed citations
16.
Liu, Yang, Yao Wang, Qian Chen, et al.. (2019). HDAC2 inhibitor CAY10683 reduces intestinal epithelial cell apoptosis by inhibiting mitochondrial apoptosis pathway in acute liver failure.. PubMed. 34(10). 1173–1184. 14 indexed citations
17.
Zhang, Wenbin, Haiyue Zhang, Yao Wang, et al.. (2019). Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice. Frontiers in Pharmacology. 10. 653–653. 11 indexed citations
18.
Jiao, Fangzhou, Yao Wang, Wenbin Zhang, et al.. (2019). Protective role of AGK2 on thioacetamide-induced acute liver failure in mice. Life Sciences. 230. 68–75. 21 indexed citations
19.
Wang, Yao, Fan Yang, Fangzhou Jiao, et al.. (2019). Modulations of Histone Deacetylase 2 Offer a Protective Effect through the Mitochondrial Apoptosis Pathway in Acute Liver Failure. Oxidative Medicine and Cellular Longevity. 2019. 1–17. 24 indexed citations
20.
Jiao, Fangzhou, Yao Wang, Haiyue Zhang, et al.. (2018). Histone Deacetylase 2 Inhibitor CAY10683 Alleviates Lipopolysaccharide Induced Neuroinflammation Through Attenuating TLR4/NF-κB Signaling Pathway. Neurochemical Research. 43(6). 1161–1170. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026